Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma

被引：0
|
作者：
Xia Li
Anne-Gaëlle Dosne
Carlos Pérez Ruixo
Juan Jose Perez Ruixo
机构：
[1] Janssen Research & Development LLC,Clinical Pharmacology and Pharmacometrics
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：761 / 777
页数：16
相关论文
共 50 条
  • [1] Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
    Li, Xia
    Dosne, Anne-Gaelle
    Ruixo, Carlos Perez
    Ruixo, Juan Jose Perez
    CLINICAL PHARMACOKINETICS, 2023, 62 (05) : 761 - 777
  • [2] Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma
    Yoon, Sung-Soo
    Byun, Ja Min
    Park, Hyunkyung
    Lee, Ji Yun
    Koh, Youngil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E155 - E156
  • [3] Effect of Bortezomib Regimens and Daratumumab Monotherapy on Cellular Immunity in Multiple Myeloma Patients
    Kakoo, Ashraf
    Rasheed, Taban
    Al-Attar, Mustafa
    IRANIAN JOURNAL OF IMMUNOLOGY, 2021, 18 (02) : 119 - 129
  • [4] Daratumumab in multiple myeloma: a guide to its use as monotherapy in the EU
    McKeage K.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (11) : 463 - 469
  • [5] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1207 - 1219
  • [6] EFFECTIVENESS AND SAFETY OF DARATUMUMAB IN MONOTHERAPY IN ADULT PATIENTS WITH RELAPSING AND REFRACTORY MULTIPLE MYELOMA (RRMM)
    Alarcon-Payer, C.
    Clavero Sanchez, M.
    Jimenez Morales, A.
    Salazar Bravo, M.
    Cornejo Calvo, M.
    Cano Dominguez, S.
    Rios Tamayo, R.
    Jurado Chacon, M.
    HAEMATOLOGICA, 2018, 103 : 122 - 122
  • [7] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Usmani, Saad
    Weiss, Brendan
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Richardson, Paul G.
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2015, 126 (23)
  • [8] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Weiss, Brendan M.
    Plesner, Torben
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Richardson, Paul G.
    Chari, Ajai
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa M.
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2016, 128 (01) : 37 - 44
  • [9] A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
    Mikhael, Joseph
    Belhadj-Merzoug, Karim
    Hulin, Cyrille
    Vincent, Laure
    Moreau, Philippe
    Gasparetto, Cristina
    Pour, Ludek
    Spicka, Ivan
    Vij, Ravi
    Zonder, Jeffrey
    Atanackovic, Djordje
    Gabrail, Nashat
    Martin, Thomas G.
    Perrot, Aurore
    Bensfia, Samira
    Weng, Qilong
    Brillac, Claire
    Semiond, Dorothee
    Mace, Sandrine
    Corzo, Kathryn P.
    Leleu, Xavier
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [10] DARATUMUMAB IN MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE IN CATALONIA
    Moreno, David Fernando
    Gomez-Hernando, Marta
    Clapes, Victoria
    Soler, Juan Alfons
    Gonzalez-Montes, Yolanda
    Gironella, Mercedes
    Motllo, Cristina
    Granell, Miquel
    Abella, Eugenia
    Garcia-Pintos, Marta
    Garcia-Guinon, Antoni
    Cabezudo, Elena
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 138 - 139
12345